Market overview
The global aniridia implants market is worth USD 14 mn in 2026 and is forecast to reach USD 29 mn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Custom artificial iris is the largest by implant segment.
| Scope | Artificial iris implants and iris reconstruction devices for aniridia, trauma and congenital iris loss, including custom-made iris and iris diaphragm rings. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 13 mn |
| Value 2026 | USD 14 mn |
| Value 2036 | USD 29 mn |
| CAGR 2026-2036 | 7.5% |
| Volume 2026 | 3,224 units |
| Volume 2036 | 6,321 units |
| Average price 2026 | USD 4,355 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Aniridia Implants market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 14 mn |
| 2027 | USD 15 mn |
| 2028 | USD 16 mn |
| 2029 | USD 17 mn |
| 2030 | USD 19 mn |
| 2031 | USD 20 mn |
| 2032 | USD 22 mn |
| 2033 | USD 23 mn |
| 2034 | USD 25 mn |
| 2035 | USD 27 mn |
| 2036 | USD 29 mn |
Aniridia Implants market segmentation
By implant
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Custom artificial iris | 44.0% | 44.8% | USD 6.2 mn | 7.7% |
| Iris diaphragm and rings | 32.0% | 28.4% | USD 4.5 mn | 6.2% |
| Foldable prosthetic iris | 24.0% | 26.8% | USD 3.4 mn | 8.7% |
By cause
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Trauma | 40.0% | 37.8% | USD 5.6 mn | 6.9% |
| Congenital aniridia | 28.0% | 29.0% | USD 3.9 mn | 7.9% |
| Ocular surgery related | 32.0% | 33.2% | USD 4.5 mn | 7.9% |
By material
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Silicone | 56.0% | 53.0% | USD 7.9 mn | 6.9% |
| Acrylic and polymethyl methacrylate | 24.0% | 25.0% | USD 3.4 mn | 7.9% |
| Polyurethane and other polymers | 20.0% | 22.0% | USD 2.8 mn | 8.5% |
By fixation
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Sclera-sutured | 44.0% | 41.0% | USD 6.2 mn | 6.7% |
| Sulcus-placed | 34.0% | 35.0% | USD 4.8 mn | 7.8% |
| Capsular bag placement | 22.0% | 24.0% | USD 3.1 mn | 8.4% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Eye hospitals | 52.0% | 51.0% | USD 7.3 mn | 7.3% |
| Academic medical centres | 30.0% | 31.0% | USD 4.2 mn | 7.8% |
| Ambulatory surgery centres | 18.0% | 18.0% | USD 2.5 mn | 7.5% |
Top 25 countries for aniridia implants by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 83.5% of 2026 revenue and the 25 countries below together hold 96.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 5.9 mn | 42.0% | USD 13 mn | 8.0% |
| 2 | Germany | USD 1.3 mn | 9.0% | USD 2.4 mn | 6.5% |
| 3 | United Kingdom | USD 0.84 mn | 6.0% | USD 1.6 mn | 7.0% |
| 4 | France | USD 0.70 mn | 5.0% | USD 1.4 mn | 7.1% |
| 5 | Japan | USD 0.70 mn | 5.0% | USD 1.4 mn | 7.1% |
| 6 | Canada | USD 0.56 mn | 4.0% | USD 1.2 mn | 7.5% |
| 7 | Italy | USD 0.49 mn | 3.5% | USD 0.95 mn | 6.9% |
| 8 | Spain | USD 0.42 mn | 3.0% | USD 0.84 mn | 7.1% |
| 9 | Australia | USD 0.42 mn | 3.0% | USD 0.87 mn | 7.5% |
| 10 | Brazil | USD 0.42 mn | 3.0% | USD 0.95 mn | 8.5% |
| 11 | China | USD 0.20 mn | 1.4% | USD 0.51 mn | 9.7% |
| 12 | Netherlands | USD 0.17 mn | 1.2% | USD 0.31 mn | 6.4% |
| 13 | Switzerland | USD 0.15 mn | 1.1% | USD 0.28 mn | 6.3% |
| 14 | Sweden | USD 0.13 mn | 0.9% | USD 0.25 mn | 6.4% |
| 15 | Belgium | USD 0.13 mn | 0.9% | USD 0.25 mn | 6.4% |
| 16 | India | USD 0.13 mn | 0.9% | USD 0.34 mn | 9.8% |
| 17 | South Korea | USD 0.13 mn | 0.9% | USD 0.28 mn | 7.6% |
| 18 | Austria | USD 0.12 mn | 0.8% | USD 0.22 mn | 6.4% |
| 19 | Turkey | USD 0.10 mn | 0.7% | USD 0.23 mn | 8.6% |
| 20 | Mexico | USD 0.10 mn | 0.7% | USD 0.21 mn | 7.5% |
| 21 | Israel | USD 0.10 mn | 0.7% | USD 0.21 mn | 7.5% |
| 22 | Russia | USD 0.10 mn | 0.7% | USD 0.19 mn | 6.2% |
| 23 | Poland | USD 84 thousand | 0.6% | USD 0.17 mn | 7.5% |
| 24 | Denmark | USD 84 thousand | 0.6% | USD 0.16 mn | 6.4% |
| 25 | Argentina | USD 84 thousand | 0.6% | USD 0.16 mn | 6.4% |
| Rest of world | USD 0.49 mn | 3.5% | USD 0.94 mn | 6.7% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- HumanOptics
- Ophtec
- Morcher
Group 2: Regional and specialist players
- Alcon
- Reper-NN
- Rayner Surgical
- Dr. Schmidt Intraocularlinsen
Group 3: Emerging and niche players
- BrightMatter
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the aniridia implants market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.
The market is divided by implant, by cause, by material, by fixation, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the aniridia implants market?
The global aniridia implants market is estimated at USD 13 mn in 2025 and USD 14 mn in 2026.
How fast will the aniridia implants market grow?
It is forecast to reach USD 29 mn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 15 mn.
Which country is the largest market for aniridia implants?
United States is the largest market by revenue at USD 5.9 mn in 2026, 42.0% of the global total. The three largest countries together hold 57.0%.
Which country is growing fastest?
Among the ten largest markets, Brazil is growing fastest at 8.5% a year from 2026 to 2036.
Which aniridia implants segment is largest?
In the by implant split, Custom artificial iris is the largest segment with 44.0% of 2026 revenue.
Who are the leading aniridia implants companies?
Global leaders include HumanOptics, Ophtec, Morcher.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Implantable Tibial NeuromodulationUSD 22 mn · 20.0% CAGR
- AI Aortic Surgery Planning ToolUSD 55 mn · 13.0% CAGR
- Colorimetric Fructosamine Assay KitUSD 57 mn · 4.8% CAGR
- At-Home Syphilis TestingUSD 58 mn · 24.0% CAGR
- Blood Bag Tube SealerUSD 58 mn · 4.5% CAGR
- Digital Colony CounterUSD 59 mn · 5.5% CAGR
- Amyotrophic Lateral Sclerosis Gene TestingUSD 62 mn · 10.5% CAGR
- Respiration Monitor BeltUSD 63 mn · 5.2% CAGR